Investigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical Cancer

NCT04405349 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Cancer
Cervix Cancer

Interventions

BIOLOGICAL: VB10.16
BIOLOGICAL: Atezolizumab

Sponsor

Nykode Therapeutics ASA

Collaborators

[object Object]
[object Object]